Mendus AB (publ) 1YG.F Stock
Mendus AB (publ) Price Chart
Mendus AB (publ) 1YG.F Financial and Trading Overview
| Mendus AB (publ) stock price | 0.02 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.03 EUR |
| Bid | 0.04 EUR x 0 |
| Ask | 0.07 EUR x 0 |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.03 - 0.31 EUR |
| Volume | 100 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 7.45M EUR |
| Beta (5Y Monthly) | 1.157854 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
1YG.F Valuation Measures
| Enterprise Value | 7.93M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.10153256 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Mendus AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.157854 |
| 52-Week Change | -80.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.31 EUR |
| 52 Week Low | 0.03 EUR |
| 50-Day Moving Average | 0.11 EUR |
| 200-Day Moving Average | 0.16 EUR |
1YG.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 10 EUR |
| Shares Outstanding | 202.7M |
| Float | 103.01M |
| Short Ratio | N/A |
| % Held by Insiders | 55.98% |
| % Held by Institutions | 11.79% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.70% |
| Return on Equity (ttm) | -25.31% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -85.00000000000000000000000000000000% |
| Gross Profit (ttm) | 3M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 22.48 EUR |
| Current Ratio (mrq) | 0.571 |
| Book Value Per Share (mrq) | 0.261 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Mendus AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | VAestra TrAedgArdsgatan 15 |
| ZIP | 111 53 |
| Phone | 46 87 32 84 00 |
| Website | https://www.mendus.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
Mendus AB (publ), a biopharmaceutical company, develops immunotherapies and relapse vaccines for the treatment of cancer. Its lead product is DCP-001, which is in Phase II ADVANCE-II clinical trial for the treatment of acute myeloid leukemia; and Phase I ALISON clinical trial for the treatment of ovarian cancers. The company's products also develops ilixadencel, which is in Phase II clinical trial for the treatment of kidney cancer; and Phase II clinical trial to treat gastrointestinal stromal tumors. It has a research collaboration with PCI Biotech Holding ASA for novel cancer vaccination treatment; and with Icahn School of Medicine at Mount Sinai. The company was formerly known as Immunicum AB (publ) and changed its name to Mendus AB (publ) in June 2022. Mendus AB (publ) was incorporated in 2002 and is headquartered in Stockholm, Sweden.
Q&A For Mendus AB (publ) Stock
What is a current 1YG.F stock price?
Mendus AB (publ) 1YG.F stock price today per share is 0.02 EUR.
How to purchase Mendus AB (publ) stock?
You can buy 1YG.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mendus AB (publ)?
The stock symbol or ticker of Mendus AB (publ) is 1YG.F.
Which industry does the Mendus AB (publ) company belong to?
The Mendus AB (publ) industry is Biotechnology.
How many shares does Mendus AB (publ) have in circulation?
The max supply of Mendus AB (publ) shares is 2.53B.
What is Mendus AB (publ) Price to Earnings Ratio (PE Ratio)?
Mendus AB (publ) PE Ratio is 0.00000000 now.
What was Mendus AB (publ) earnings per share over the trailing 12 months (TTM)?
Mendus AB (publ) EPS is 0 EUR over the trailing 12 months.
Which sector does the Mendus AB (publ) company belong to?
The Mendus AB (publ) sector is Healthcare.